当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 利润表

金陵药业

(000919)

  

流通市值:40.97亿  总市值:43.16亿
流通股本:5.90亿   总股本:6.22亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入1,601,071,008.21810,013,922.673,281,450,554.732,220,261,162.73
  营业收入1,601,071,008.21810,013,922.673,281,450,554.732,220,261,162.73
  利息收入000-
  已赚保费000-
  手续费及佣金收入000-
二、营业总成本1,565,898,002.66788,644,161.763,232,853,911.512,142,170,897.07
  营业成本1,289,905,608.04653,156,391.472,675,775,027.91,770,400,774.84
  利息支出000-
  手续费及佣金支出000-
  退保金000-
  赔付支出净额000-
  提取保险合同准备金净额000-
  保单红利支出000-
  分保费用000-
  税金及附加10,064,279.064,488,460.3320,920,658.3214,856,726.04
  销售费用41,514,693.2122,006,480.9885,576,755.2267,467,572.06
  管理费用183,261,110.0490,715,196.32361,153,458.4239,296,887.95
  研发费用45,341,568.6621,182,611.02110,692,239.5464,403,035.8
  财务费用-4,189,256.35-2,904,978.36-21,264,227.87-14,254,099.62
  其中:利息费用2,574,532.95922,117.212,195,885.9259,542.81
  其中:利息收入7,243,139.144,451,970.2324,298,098.5314,730,509.21
三、其他经营收益
  加:公允价值变动收益12,013,263.09-1,067,815.2414,387,532.6417,868,995.47
  加:投资收益11,824,341.539,392,399.0339,616,814.17-6,751,210.62
  净敞口套期收益000-
  汇兑收益000-
  资产处置收益-44,966.62-10,436.1221,343,277.64124,411.49
  资产减值损失(新)00-92,511,196.6919,683.1
  信用减值损失(新)-1,901,062.12-1,722,880.19-1,051,685.9-5,389,403.11
  其他收益3,425,735.471,567,564.3612,577,850.977,439,936.25
四、营业利润60,490,316.929,528,592.7542,959,236.0591,402,678.24
  加:营业外收入720,443.13757,290.712,694,575.711,608,332.2
  减:营业外支出221,742.26104,609.95,647,735.43626,351.31
五、利润总额60,989,017.7730,181,273.5640,006,076.3392,384,659.13
  减:所得税费用10,572,092.455,006,368.322,052,043.1620,230,217.89
六、净利润50,416,925.3225,174,905.2617,954,033.1772,154,441.24
(一)按经营持续性分类
  持续经营净利润50,416,925.3225,174,905.2617,954,033.1772,154,441.24
  终止经营净利润00--
(二)按所有权归属分类
  归属于母公司股东的净利润48,333,532.4522,981,989.1440,409,795.7471,368,654.3
  少数股东损益2,083,392.872,192,916.12-22,455,762.57785,786.94
  扣除非经常损益后的净利润35,510,166.1620,439,820.6548,922,210.8445,648,760.8
七、每股收益
  (一)基本每股收益0.080.040.070.12
  (二)稀释每股收益0.080.040.070.12
八、其他综合收益00-59,087.2639,230.41
  归属于母公司股东的其他综合收益00-14,401.8839,230.41
九、综合收益总额50,416,925.3225,174,905.2617,894,945.9172,193,671.65
  归属于母公司股东的综合收益总额48,333,532.4522,981,989.1440,395,393.8671,407,884.71
  归属于少数股东的综合收益总额2,083,392.872,192,916.12-22,500,447.95785,786.94
公告日期2025-08-282025-04-282025-03-292024-10-29
审计意见(境内)标准无保留意见
TOP↑